Nexium and Ingrezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nexium (esomeprazole magnesium) and Ingrezza (valbenazine tosylate). Common drug interactions include staring among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Nexium and Ingrezza. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

On Jul, 14, 2026

81 people who take Nexium and Ingrezza together, and have interactions are studied.

What are the common drug interactions of Nexium and Ingrezza, by gender? *:

female:

Staring (a prolonged gaze or fixed look)
Suicidal ideation
Visual impairment
Tardive dyskinesia (a disorder that involves involuntary movements)
Drug ineffective
Fall
Fatigue (feeling of tiredness)
Dyskinesia (abnormality or impairment of voluntary movement)
Insomnia (sleeplessness)
Dry mouth

male:

Fatigue (feeling of tiredness)
Somnolence (a state of near-sleep, a strong desire for sleep)
Increased appetite
Insomnia (sleeplessness)
Loss of consciousness
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Urinary retention (the inability to completely or partially empty the bladder)
Weight increased
Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

What are the common drug interactions of Nexium and Ingrezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Initial insomnia (feeling of inadequate or poor-quality sleep)
Insomnia (sleeplessness)
Weight increased

30-39:

Dyspnoea (difficult or laboured respiration)
Completed suicide (act of taking one's own life)

40-49:

Confusional state
Drooling (drop saliva uncontrollably from the mouth)
Dyskinesia (abnormality or impairment of voluntary movement)
Hyperhidrosis (abnormally increased sweating)
Depression
Knee arthroplasty
Post procedural infection
Suicidal ideation
Adverse drug reaction

50-59:

Dizziness
Tardive dyskinesia (a disorder that involves involuntary movements)
Emotional disorder
Restlessness (not able to rest)
Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
Depressed mood
Depression
Dry mouth

60+:

Fatigue (feeling of tiredness)
Tardive dyskinesia (a disorder that involves involuntary movements)
Aggression
Tremor (trembling or shaking movements in one or more parts of your body)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Dizziness
Dry mouth
Dysarthria (speech disorder)
Increased appetite
Loss of consciousness

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 63 people, 77.78%
Depression: 9 people, 11.11%
Stress And Anxiety: 7 people, 8.64%
Pain: 6 people, 7.41%
Hypersensitivity: 6 people, 7.41%
High Blood Cholesterol: 6 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Nexium and Ingrezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously